The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial-Reference-Cited by-同舟云学术

The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial

Published:2014-12-29 Issue:12 Volume:9 Page:e116306
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Somsouk Ma,Dunham Richard M.,Cohen Michelle,Albright Rebecca,Abdel-Mohsen Mohamed,Liegler Teri,Lifson Jeffrey,Piatak Michael,Gorelick Robert,Huang Yong,Wu Yuaner,Hsue Priscilla Y.,Martin Jeffrey N.,Deeks Steven G.,McCune Joseph M.,Hunt Peter W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity;SG Deeks;Bmj,2009

2. Survival of persons with and without HIV infection in Denmark, 1995–2005;N Lohse;Ann Intern Med,2007

3. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population;C Lewden;J Acquir Immune Defic Syndr,2007

4. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies;Collaboration Antiretroviral Therapy Cohort;Lancet,2008

5. Microbial translocation is a cause of systemic immune activation in chronic HIV infection;JM Brenchley;Nat Med,2006

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy;Microbiome;2024-06-21

2. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease;Frontiers in Immunology;2024-05-08

3. Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV;eBioMedicine;2023-09

4. Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy;AIDS;2023-08-22

5. An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV;AIDS;2023-07-24